BioSpace News Archive

BioMidwest

Bio-Techne’s Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana

Bio-Techne Corporation announced that Humana has awarded a contract effective April 1, 2021 to its Exosome Diagnostics laboratory, covering the ExoDx™ Prostate test for men.

March 1, 2021
·
2 min read
Biotech Bay

Apexigen to Present at Investor Conferences in March and April 2021

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced that Xiaodong Yang , M.D., Ph.D., President and Chief Executive Officer, will present at the following upcoming investor conferences:

March 1, 2021
·
1 min read
Business

Centene Corporation Announces Executive Leadership Appointments - Mar 01, 2021

Centene Corporation announced four executive leadership appointments to support the company’s continued growth and innovation.

March 1, 2021
·
11 min read
Deals

Oxular raises $37 million

Oxular Limited, a leading retinal therapeutics development company, announced that it has completed a $37 million financing led by Forbion.

March 1, 2021
·
5 min read
Business

Syndax to Announce Fourth Quarter and Year-end 2020 Financial Results and Host Conference Call and Webcast on March 8, 2021

Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced today that it will release its fourth quarter and year-end 2020 financial results on Monday, March 8 , after the close of the U.S. financial market

March 1, 2021
·
1 min read
Deals

Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration

Cash proceeds of $1.5 billion substantially enhances financial flexibility and optionality to create long-term shareholder value

March 1, 2021
·
7 min read
Biotech Beach

Ionis establishes new grant program to advance research and understanding of transthyretin amyloidosis

Ionis Pharmaceuticals (NASDAQ: IONS) today announced that the company has launched a new grant program that provides funding to U.S.-based researchers whose work advances the understanding of transthyretin amyloidosis (ATTR), facilitates early diagnosis and enhances disease management of patients living with ATTR amyloidosis.

March 1, 2021
·
3 min read
BioMidwest

Epsilon Imaging Partners With Siemens Healthineers to Offer Echoinsight® Visualization and Analysis Strain Imaging to syngo® Dynamics Users

EchoInsight® Strain imaging Standardizes Analysis and Interpretation, while Improving Diagnostic Assessment and Optimizing Care Through Better Patient Monitoring

March 1, 2021
·
3 min read
IMV to Participate at the upcoming H.C. Wainwright Global Life Sciences Conference

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today announced that IMV’s executive management team will be participating at the H.C. Wainwright Global Life Sciences Conference which will be held virtually on March 9-10.

March 1, 2021
·
3 min read
Business

4D Pharma Appoints John Beck as Chief Financial Officer and Member of the Management Team

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces the appointment of John Beck as Chief Financial Officer (CFO) and member of the Company’s management team

March 1, 2021
·
9 min read